Whereas Wang et al. described a greater percentage of IL-17-producing CD4+ cells (considered as Th17 cells) in the peripheral blood of NASH patients compared to NAFL or healthy controls [84], Rau et al. did not find any differences [82]. This evidence concerns the gene CD4 and metabolic dysfunction-associated steatohepatitis.